Dosage & Administration Drug label Financial assistance

Genvoya

(cobicistat / elvitegravir / emtricitabine / tenofovir alafenamide)

Genvoya 150 MG / 150 MG / 200 MG / 10 MG Oral Tablet

Dosage & administration

* Testing: Prior to or when initiating GENVOYA test for hepatitis B virus infection. Prior to or when initiating GENVOYA, and during treatment on a clinically appropriate schedule, assess serum creatinine, estimated creatinine clearance, urine glucose, and urine protein in all patients. In patients with chronic kidney disease, also assess serum phosphorus.
* Recommended dosage in adult and pediatric patients weighing at least 25 kg: One tablet taken orally once daily with food in patients with body weight at least 25 kg and a creatinine clearance greater than or equal to 30 mL per minute, or in adult patients with creatinine clearance less than 15 mL per minute who are receiving chronic hemodialysis. On days of hemodialysis, administer GENVOYA after hemodialysis.
* Renal impairment: GENVOYA is not recommended in patients with estimated creatinine clearance of 15 to below 30 mL per minute, or below 15 mL per minute who are not receiving chronic hemodialysis.
* Hepatic impairment: GENVOYA is not recommended in patients with severe hepatic impairment.

drug label

Genvoya prescribing information

Contact Medical Science Liaison Report Adverse Event

financial assistance

Genvoya financial assistance options

Co-pay savings program

commercial only

Enroll in Patient Savings Program

Activate Co-Pay Card (if already have one)

Replace Co-Pay card (if lost one)

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Foundation programs

under insured

no insurance

goverment insurance

65+

Patient Assistance Program

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Genvoya patient education

To share resource; ask patient to:

1.Pull out phone

2.Open camera

3.Scan QR code with camera

4.Tap link

Patient toolkit

Genvoya Tear Sheet

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Learn More

Genvoya FAQs

How is the dosage of Genvoya?Genvoya is available in 1 dosages, including 150-150-200-10 mg Tab

What does Genvoya treat?Genvoya treats HIV Infections and Chronic Hepatitis B

What is Genvoya made of?Genvoya contains cobicistat / elvitegravir / emtricitabine / tenofovir alafenamide which is a Cytochrome P450 3A Inhibitor

How Is Genvoya Administered?Genvoya is administered as a Oral Pill

What Are The Genvoya Mechanism Of Action?Genvoya mechanism of action is Breast Cancer Resistance Protein Inhibitors, Cytochrome P450 2C9 Inducers, Cytochrome P450 2D6 Inhibitors, Cytochrome P450 3A Inhibitors, HIV Integrase Inhibitors, Nucleoside Reverse Transcriptase Inhibitors, Organic Anion Transporting Polypeptide 1B1 Inhibitors, Organic Anion Transporting Polypeptide 1B3 Inhibitors or P-Glycoprotein Inhibitors

FAQ Data Source

Genvoya

Dosage & administration

drug label

Genvoya prescribing information

financial assistance

Genvoya financial assistance options

Co-pay savings program

Foundation programs

patient education

Genvoya patient education

Patient toolkit

people also ask

Genvoya FAQs